Investor Meeting Full Year Results; year ended Mar 31, 2008

Takakazu Morita Chairman and CEO	Summary of the Year Ended March 2008 Forecast of the Year Ending March 2009 Status of 2006-2010 Medium-term Management Plan Policy for Return to Shareholders (PDF: 115KB)PDF file.
Akira Kurokawa President and COO	Consolidated Financial Results for the Year Ended March 31, 2008 Consolidated Financial Forecasts for the Year Ending March, 2009 (PDF: 377KB)PDF file
Toshiaki Nishihata, Ph.D. Senior Corporate Officer Head of Research and Development Division	Status of Clinical Development (PDF: 113KB)PDF file